A recent study showed that IL-35 can reduce airway eosinophilia through the inhibition of eosinophil-attracting chemokines (CCL24 and CCL11) and concluded that IL-35 could be a treatment option for reducing the recruitment of eosinophils into tissues in disorders such as asthma [37]. This evidence concerns the gene CCL11 and asthma.